These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 34490386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs.
    Her J, Kuo KW, Winter RL, Cruz-Espindola C, Bacek LM, Boothe DM.
    Front Vet Sci; 2020; 7():423. PubMed ID: 32851013
    [Abstract] [Full Text] [Related]

  • 5. Single-dose pharmacokinetics and cardiovascular effects of oral pimobendan in healthy cats.
    Yata M, McLachlan AJ, Foster DJ, Hanzlicek AS, Beijerink NJ.
    J Vet Cardiol; 2016 Dec; 18(4):310-325. PubMed ID: 27613648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs.
    Saengklub N, Boonyarattanasoonthorn T, Kijtawornrat A, Chantasart D.
    Vet Sci; 2022 Mar 17; 9(3):. PubMed ID: 35324869
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study.
    Enokizono M, Mandour AS, Komeda S, Goya S, Takeuchi A, Katoh K, Yairo A, Yilmaz Z, Shimada K, Tanaka R.
    Front Vet Sci; 2022 Mar 17; 9():969304. PubMed ID: 36311676
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of the utility of LVdP/dt40, QA interval, LVdP/dtmin and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs.
    Pugsley MK, Guth B, Chiang AY, Doyle JM, Engwall M, Guillon JM, Hoffmann PK, Koerner JE, Mittelstadt SW, Pierson JB, Rossman EI, Sarazan DR, Parish ST.
    J Pharmacol Toxicol Methods; 2017 Mar 17; 85():1-21. PubMed ID: 28065821
    [Abstract] [Full Text] [Related]

  • 11. Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs.
    Hori Y, Taira H, Nakajima Y, Ishikawa Y, Yumoto Y, Maekawa Y, Oshiro A.
    J Vet Med Sci; 2019 Jan 08; 81(1):22-25. PubMed ID: 30404952
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC, Diederen W.
    J Cardiovasc Pharmacol; 1989 Jan 08; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease.
    McManamey AK, DeFrancesco TC, Meurs KM, Papich MG.
    J Vet Intern Med; 2023 Jan 08; 37(6):2003-2010. PubMed ID: 37776546
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS, Hettrick DA, Warltier DC.
    Basic Res Cardiol; 1996 Jan 08; 91(4):296-307. PubMed ID: 8874779
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.